FAERS is publicly available and anonymous, so approval and written informed consent were waived by the ethics review board of the Ethical Committee of Fujian Medical University
The approval is also an endorsement of our science, scale and expertise to develop high quality, more affordable insulins and shift the access paradigm in favour of patients, taking us closer to realizing our aspiration of reaching 'one in five' insulin dependent people with diabetes worldwide." Dr Christiane Hamacher, CEO & Managing Director, Biocon Biologics said, "We are extremely excited with the opportunity to offer Semglee, co-developed with Mylan and manufactured by Biocon Biologics, to the U.S
Take Our Quiz To discover which supplements may best suit your health goals, we invite you to take our AI quiz
Those with asparagine-glycine or glutamine-glycine sequences are prone to deamidation
Boots Online Doctor provides digital consultations with UK-registered clinicians, home delivery, and ongoing monitoring for treatment response and safety